Iranian Journal of War and Public Health

eISSN (English): 2980-969X
eISSN (Persian): 2008-2630
pISSN (Persian): 2008-2622
JMERC
0.4
Volume 15, Issue 2 (2023)                   Iran J War Public Health 2023, 15(2): 133-139 | Back to browse issues page

Print XML PDF HTML Full-Text (HTML)


History

How to cite this article
Ibraheim W. Molecular Determination of Toll-Like Receptors 2 and 4 among Asthmatic Patients in Basrah, South Iraq. Iran J War Public Health 2023; 15 (2) :133-139
URL: http://ijwph.ir/article-1-1355-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rights and permissions
Authors W.N. Ibraheim *
Department of Microbiology, College of Medicine, University of Basrah, Basrah, Iraq
* Corresponding Author Address: Department of Microbiology, College of Medicine, University of Basrah, Basrah, Iraq. (wijdan.ibraheim@uobasrah.edu.iq)
Abstract   (718 Views)
Aims: Bronchial asthma is a life-threatening disease with a multifactorial etiology. It was shown that immunological dysregulations play an essential role in the exacerbation of the patient’s attacks. Toll-like receptors act as a bridge in the transmission of different signals associated with the regulation of immune responses. According to numerous research, TLR2 causes different outcomes in asthma. TLR2 and TLR4 overexpression seems to predispose to an increase in the frequency of dyspneic attacks. Therefore, this study aimed to learn more about the function of TLR2 and TLR4 and investigate their underlying association with allergic airway inflammation in asthmatic patients.
Materials & Methods: In this case-control study conducted at outpatient clinics in a Specialized Allergy Center in Basrah City, South of Iraq, 70 asthmatic patients and 70 healthy individuals were investigated. 4ml of venous blood was drawn and divided into two parts: 2ml was used for RNA extraction and qRT-PCR, and another 2ml was used for the serological tests. Data analysis was done by SPSS 26 software.
Findings: The mean serum levels of TLR2 and TLR4 were significantly higher in the asthmatic group (28.33±13.00ng/ml and 46.30±20.32ng/ml, respectively) than in the control group (7.33±3.73ng/ml and 26.28±14.32ng/ml, respectively). Also, the expression level of TLR2 and TLR4 was significantly higher in the asthmatic group (p<0.05).
Conclusion: TLR2 and TLR4 are increased in patients with bronchial asthma compared to healthy individuals. Elevated levels of both biomarkers may act as a trigger for increased secretion of other cytokines, leading to exacerbation of asthmatic signs and symptoms.
Keywords:

References
1. Mandlik DS, Mandlik SK. New perspectives in bronchial asthma: pathological, immunological alterations, biological targets, and pharmacotherapy. Immunopharmacol Immunotoxicol. 2020;42(6):521-44. [Link] [DOI:10.1080/08923973.2020.1824238]
2. Behera D, Sehgal IS. Bronchial asthma - Issues for the developing world. Indian J Med Res. 2015;141(4):380-2. [Link] [DOI:10.4103/0971-5916.159237]
3. Masoli M, Fabian D, Holt S, Beasley R, Global Initiative for Asthma (GINA) Programme. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469-78. [Link] [DOI:10.1111/j.1398-9995.2004.00526.x]
4. To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12:204. [Link] [DOI:10.1186/1471-2458-12-204]
5. Quirt J, Hildebrand KJ, Mazza J, Noya F, Kim H. Practical guide for allergy and immunology in Canada 2018. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):50. [Link] [DOI:10.1186/s13223-018-0279-0]
6. Lemanske RF, Busse WW. Asthma: clinical expression and molecular mechanisms. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S95-102. [Link] [DOI:10.1016/j.jaci.2009.10.047]
7. Lotvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol. 2011;127(2):355-60. [Link] [DOI:10.1016/j.jaci.2010.11.037]
8. Schatz M, Rosenwasser L. The allergic asthma phenotype. J Allergy Clin Immunol Pract 2014;2(6):645-8. [Link] [DOI:10.1016/j.jaip.2014.09.004]
9. Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56(9):813-24. [Link] [DOI:10.1034/j.1398-9995.2001.t01-1-00001.x]
10. Haapakoski R, Karisola P, Fyhrquist N, Savinko T, Lehtimäki S, Wolff H, et al. Toll-like receptor activation during cutaneous allergen sensitization blocks development of asthma through IFN-gamma-dependent mechanisms. J Invest Dermatol. 2013;133(4):964-72. [Link] [DOI:10.1038/jid.2012.356]
11. Peebles RS Jr, Aronica MA. Proinflammatory pathways in the pathogenesis of asthma. Clin Chest Med. 2019;40(1):29-50. [Link] [DOI:10.1016/j.ccm.2018.10.014]
12. Mak TW, Saunders ME. Immunity to pathogens. Immune Resp. 2006:641-94. [Link] [DOI:10.1016/B978-012088451-3.50024-7]
13. Phipps S, Lam CE, Foster PS, Matthaei KI. The contribution of toll-like receptors to the pathogenesis of asthma. Immunol Cell Biol. 2007;85(6):463-70. [Link] [DOI:10.1038/sj.icb.7100104]
14. Lebold KM, Jacoby DB, Drake MG. Toll-like receptor 7-targeted therapy in respiratory disease. Transfus Med Hemother. 2016;43(2):114-9. [Link] [DOI:10.1159/000445324]
15. Crespo-Lessmann A, Juárez-Rubio C, Plaza-Moral V. Role of toll-like receptors in respiratory diseases. Arch Bronconeumol. 2010;46(3):135-42. [Spanish] [Link] [DOI:10.1016/S1579-2129(10)70034-3]
16. Behzadi P, García-Perdomo HA, Karpiński TM. Toll-like receptors: general molecular and structural biology. J Immunol Res. 2021;2021:9914854. [Link] [DOI:10.1155/2021/9914854]
17. Duan T, Du Y, Xing C, Wang HY, Wang RF. Toll-like receptor signaling and its role in cell-mediated immunity. Front Immunol. 2022;13:812774. [Link] [DOI:10.3389/fimmu.2022.812774]
18. Farooq M, Batool M, Kim MS, Choi S. Toll-like receptors as a therapeutic target in the era of immunotherapies. Front Cell Dev Biol. 2021;9:756315. [Link] [DOI:10.3389/fcell.2021.756315]
19. Heine H, Lien E. Toll-like receptors and their function in innate and adaptive immunity. Int Arch Allergy Immunol. 2003;130(3):180-92. [Link] [DOI:10.1159/000069517]
20. Al-Kasser MK. Air pollution in Iraq sources and effects. IOP Conf Ser Earth Environ Sci. 2021;790:012014. [Link] [DOI:10.1088/1755-1315/790/1/012014]
21. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002;4(4):278-99. [Link] [DOI:10.1093/neuonc/4.4.278]
22. Spandidos A, Wang X, Wang H, Seed B. PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res. 2010;38(Database issue):D792-9. [Link] [DOI:10.1093/nar/gkp1005]
23. Pombo-Suarez M, Calaza M, Gomez-Reino JJ, Gonzalez A. Reference genes for normalization of gene expression studies in human osteoarthritic articular cartilage. BMC Mol Biol. 2008;9:17. [Link] [DOI:10.1186/1471-2199-9-17]
24. Malvandi AM, Mehrzad J, Moghaddam MS. Gene expression quantification of toll like receptors 2, 4 and co-molecules in human glioblastoma cell line (U87-MG): toward a new in vitro model of inflammation. Iran J Basic Med Sci. 2011;14(5):428-35. [Link]
25. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101-8. [Link] [DOI:10.1038/nprot.2008.73]
26. Badr Z, AL-Moosawi W, Ali S. Evaluation of VEGF-A in relation to childhood acute lymphoblastic leukemia (in Basrah, Iraq): Evaluation of VEGF-A in relation to childhood acute lymphoblastic leukemia (in Basrah, Iraq). Iraqi Nation J Med. 2021;3(1):39-44. [Link] [DOI:10.37319/iqnjm.3.1.4]
27. National Heart Lung, and Blood Institute. National asthma education program expert panel report. Guidelines for the diagnosis and management of asthma. J Allergy Clin Immunol. 1991;88(3 Pt 2):425-534. [Link]
28. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med. 1992;326(13):862-6. [Link] [DOI:10.1056/NEJM199203263261304]
29. Obel KB, Ntumba KJM, Kalambayi KP, Zalagile AP, Munogolo KZ. Prevalence and determinants of asthma in adults in Kinshasa. PLoS One. 2017;12(5):e0176875. [Link] [DOI:10.1371/journal.pone.0176875]
30. Lajoie P, Dagenais G, Ernst P, Neukirch F, Gérin M, Gosselin P, et al. Systèmes respiratoire et cardio-vasculaire. Environnement et Santé Publique-Fondements et Pratiques. 2003:713-45. [Link]
31. Trasande L, Thurston GD. The role of air pollution in asthma and other pediatric morbidities. J Allergy Clin Immunol. 2005;115(4):689-99. [Link] [DOI:10.1016/j.jaci.2005.01.056]
32. Carrillo G, Patron MJP, Johnson N, Zhong Y, Lucio R, Xu X. Asthma prevalence and school-related hazardous air pollutants in the US-Mexico border area. Environ Res. 2018;162:41-8. [Link] [DOI:10.1016/j.envres.2017.11.057]
33. Shukur W, Alyaqubi K, Dosh R, Al-Ameri A, Al-Aubaidy H, Al-Maliki R. Association of Toll-like receptors 4 (TLR-4) gene expression and polymorphisms in patients with severe asthma. J Med Life. 2021;14(4):544-8. [Link] [DOI:10.25122/jml-2021-0173]
34. Wu X, Wang P, Zhang Y, Gao L, Zheng B, Xu Y, et al. Toll-like receptor characterization correlates with asthma and is predictive of diagnosis. DNA Cell Biol. 2020;39(7):1313-21. [Link] [DOI:10.1089/dna.2020.5543]
35. Lee JE, Kim YH, Rhee CS, Kim DY. Synergistic effect of dermatophagoidesfarinae and lipopolysaccharide in human middle ear epithelial cells. Allergy Asthma Immunol Res. 2016;8(5):445-56. [Link] [DOI:10.4168/aair.2016.8.5.445]
36. Ahmad SK, Ibrahim HA. Some risk factors of asthma in bronchial asthma patient in Sulaimani City- Iraq. Mosul J Nurs. 2022;10(2):226-42. [Link] [DOI:10.33899/mjn.2022.175440]
37. Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol. 2014;5:461. [Link] [DOI:10.3389/fimmu.2014.00461]
38. Sameer AS, Nissar S. Toll-Like Receptors (TLRs): Structure, functions, signaling, and role of their polymorphisms in colorectal cancer susceptibility. Biomed Res Int. 2021;2021:1157023. [Link] [DOI:10.1155/2021/1157023]
39. Kim S, Becker J, Bechheim M, Kaiser V, Noursadeghi M, Fricker N, et al. Characterizing the genetic basis of innate immune response in TLR4-activated human monocytes. Nature Communications. 2014;5:5236. [Link] [DOI:10.1038/ncomms6236]
40. Liu J, Cao S, Kim S, Chung EY, Homma Y, Guan X, et al. Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression. Curr Immunol Rev. 2005;1(2):119-37. [Link] [DOI:10.2174/1573395054065115]
41. Duan T, Du Y, Xing C, Wang HY, Wang RF. Toll-like receptor signaling and its role in cell-mediated immunity. Front Immunol. 2022;13:812774. [Link] [DOI:10.3389/fimmu.2022.812774]
42. Chun E, Lee SH, Lee SY, Shim EJ, Cho SH, Min KU, et al. Toll-like receptor expression on peripheral blood mononuclear cells in asthmatics; implications for asthma management. J Clin Immunol. 2010;30(3):459-64. [Link] [DOI:10.1007/s10875-009-9363-z]
43. Wills-Karp M. Allergen-specific pattern recognition receptor pathways. Curr Opin Immunol. 2010;22(6):777-82. [Link] [DOI:10.1016/j.coi.2010.10.011]
44. Zhao J, Shang H, Cao X, Huang Y, Fang X, Zhang S, et al. Association of polymorphisms in TLR2 and TLR4 with asthma risk. Medicine (Baltimore). 2017;96(35):e7909. [Link] [DOI:10.1097/MD.0000000000007909]
45. Zuo L, Lucas K, Fortuna CA, Chuang CC, Best TM. Molecular regulation of toll-like receptors in asthma and COPD. Front Physiol. 2015;6:312. [Link] [DOI:10.3389/fphys.2015.00312]
46. Fang L, Shen Q, Wu H, He F, Ding P, Xu K, et al. TLR2 favors OVA-induced allergic airway inflammation in mice through JNK signaling pathway with activation of autophagy. Life Sci. 2020;256:117896. [Link] [DOI:10.1016/j.lfs.2020.117896]
47. Muzio M, Fonte E, Caligaris-Cappio F. Toll-like receptors in chronic lymphocytic leukemia. Mediterr J Hematol Infect Dis. 2012;4(1):e2012055. [Link] [DOI:10.4084/mjhid.2012.055]
48. Wang Y, McCusker C. Neonatal exposure with LPS and/or allergen prevents experimental allergic airways disease: development of tolerance using environmental antigens. J Allergy Clin Immunol. 2006;118(1):143-51. [Link] [DOI:10.1016/j.jaci.2006.03.020]
49. Klaassen EM, Thönissen BE, van Eys G, Dompeling E, Jöbsis Q. A systematic review of CD14 and toll-like receptors in relation to asthma in Caucasian children. Allergy Asthma Clin Immunol. 2013;9(1):10. [Link] [DOI:10.1186/1710-1492-9-10]
50. Echem C, Akamine EH. Toll-like receptors represent an important link for sex differences in cardiovascular aging and diseases. Front Aging. 2021;2:709914. [Link] [DOI:10.3389/fragi.2021.709914]
51. Salem MB, Al-Sadoon IO, Hassan MK. Prevalence of wheeze among preschool children in Basra governonate, southern Iraq. East Mediterr Health J. 2002;8(4-5):503-8. [Link] [DOI:10.26719/2002.8.4-5.503]
52. Al-Thamiri D, Al-Kubaisy W, Ali SH. Asthma prevalence and severity among primary-school children in Baghdad. 2005;11(1-2):79-86. [Link]
53. Oleś D, Szczepankiewicz A. Role of Toll-like receptors in the development of allergic inflammation in asthma. Adv Dermatol Allergol. 2012;29(4):275-8. [Link] [DOI:10.5114/pdia.2012.30467]
54. Zakeri A, Russo M. Dual role of Toll-like receptors in human and experimental asthma models. Front Immunol. 2018;9:1027. [Link] [DOI:10.3389/fimmu.2018.01027]
55. Ekman AK, Adner M, Cardell LO. Toll-like receptor 7 activation reduces the contractile response of airway smooth muscle. Eur J Pharmacol. 2011;652(1-3):145-51. [Link] [DOI:10.1016/j.ejphar.2010.11.009]

Add your comments about this article : Your username or Email:
CAPTCHA